Navigation Links
Dancing atoms now understood
Date:11/26/2008

In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance.

The new understanding may eventually lead to better control of magnetic resonance imaging (MRI) and higher resolution MRI diagnoses.

Collaborators at Ohio State University in Columbus and three institutions in France--the Centre National de la Recherche Scientifique, the Universit d'Orlans, and the Universit de Lyon--presented their findings in a paper that appears early online Nov. 25, 2008, in the Journal of Chemical Physics.

"This is very exciting work", said Tanja Pietra, the program officer at the National Science Foundation who partially supported this project. "The fact that the researchers did not set out to work on this problem but more or less stumbled upon it and then used their ingenuity to solve it, demonstrates the importance of conducting basic research. In this case, the work may have a major impact on magnetic resonance imaging, positively affecting many peoples' lives."

The key breakthrough is a new understanding of a type of physical process called adiabaticity. Adiabatic processes are what physicists and engineers routinely use to control atoms in nuclear magnetic resonance (NMR) spectroscopy, and its better known sister, MRI.

"An adiabatic process can be visualized as one where a system is 'held tightly'and slowly dragged by a controlling force from one state to the next," said chemist Philip Grandinetti of Ohio State. In MRI, magnetic energy holds the atoms in a patient's body in a steady state while radio waves are the controlling force that drags the atoms from one state to the next. "In a 'perfect' adiabatic process, the controlling force is moved infinitely slowly with the system's trajectory locked to the controlling force's trajectory," said Grandinetti.

Both NMR and MRI exploit a pe
'/>"/>

Contact: Josh Chamot
jchamot@nsf.gov
703-292-7730
National Science Foundation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Super atoms turn the periodic table upside down
2. Diatoms discovered to remove phosphorus from oceans
3. Heftier atoms reduce friction at the nanoscale, study led by Penn researcher reveals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Conn. , Jul. 31, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies such ... by introducing a common, uniform way to manage all ...
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
(Date:7/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ... "Global Outlook of the Biometrics Industry 2015 " ... The global biometrics market is likely to witness ... owing to the uptake of multiple technologies available. ... enhances the growth of biometrics in existing applications ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... at the Johns Hopkins School of Medicine have discovered ... protein, critical for the development of spinal cord neurons. ... describes a never-before known mechanism of protein control. ... of chemical reaction control neuronal differentiation," says Shanthini Sockanathan, ...
... September 17th, 2009 / b3c newswire / - ... based on a 96 well plate. The System ... EMBL (European Molecular Biology Laboratory). , PROcellcare ... (in vitro) under the microscope with biological nutrient ...
... cells in the body could help scientists better understand how ... have found that the protein invadolysin, which is essential for ... parts of cells used to store fat. The study ... reduced amounts of fat deposits. The findings, published in ...
Cached Biology News:Antioxidant controls spinal cord development 2New Automatic cell feeding station PROcellcare for life cell imaging 2
(Date:7/29/2015)... ... July 29, 2015 , ... ... supplier, announces the launch of their 2nd generation cell therapy POD® design. The ... CT, but it also represents a new POD® design. , “G-CON first ...
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
(Date:7/29/2015)... 2015  Indivior PLC (LON: INDV) today announced that ... was accepted and received Priority Review by the U.S. ... opioid overdose. This naloxone nasal spray comes as a ... absorption into the nasal mucosa. 1 The device ... may be better equipped to help an opioid overdose ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... , PHILADELPHIA, Sept. 16 BioNanomatrix, Inc., a ... and personalized medicine, today announced that Dr. Charles Lee and ... Dr. Lee is a pioneer in the field of ... Medical School and the Broad Institute. Dr. Barker, the ...
... , , , ... Pervasis Therapeutics, Inc. today announced that it completed the ... financing. The proceeds will be used primarily to support ... biologically active therapy designed to reestablish healthy vasculature following ...
... DENVER, Colorado and JERUSALEM, September 16 ... Venture announced today,that Children,s Hospital is enrolling patients for ... series of cord blood transplant sites,worldwide, five of which ... Spain, Italy, Hungary and Israel. The trial is researching ...
Cached Biology Technology:BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 2BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 3BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 4Pervasis Therapeutics Announces $17 Million in Financing and New Board Member 2Pervasis Therapeutics Announces $17 Million in Financing and New Board Member 3Pervasis Therapeutics Announces $17 Million in Financing and New Board Member 4Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma 2Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma 3Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma 4
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
... System is ideal for developing single and ... system contains the new, improved, and user ... user can design specific templates for commercial ... fully integrated graphing and data regression capabilities; ...
...
... GeneSwitch Cell Lines stably express the ... cell line is functionally tested for ... the expression control vector pGene/V5-His/lacZ and ... treatment with mifepristone (Figure 1). These ...
Biology Products: